Stay updated on Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.

Latest updates to the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous entry v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and the notices about funding lapse and operating status tied to earlier revisions were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a system notice about a lapse in government funding. Updated the revision to v3.4.1; the previous revision v3.4.0 was removed.SummaryDifference0.6%

- Check48 days agoChange DetectedDifference0.8%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added and an older revision v3.3.3 was removed. There are no changes to the core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter updates: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.